The genetic basis for cardiac remodeling

F Ahmad, JG Seidman… - Annu. Rev. Genomics Hum …, 2005 - annualreviews.org
▪ Abstract Cardiomyopathies are primary disorders of cardiac muscle associated with
abnormalities of cardiac wall thickness, chamber size, contraction, relaxation, conduction …

[HTML][HTML] Genetic causes of human heart failure

H Morita, J Seidman, CE Seidman - The Journal of clinical …, 2005 - Am Soc Clin Investig
Factors that render patients with cardiovascular disease at high risk for heart failure remain
incompletely defined. Recent insights into molecular genetic causes of myocardial diseases …

A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice

EM Green, H Wakimoto, RL Anderson, MJ Evanchik… - Science, 2016 - science.org
Hypertrophic cardiomyopathy (HCM) is an inherited disease of heart muscle that can be
caused by mutations in sarcomere proteins. Clinical diagnosis depends on an abnormal …

Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function

RF Sommese, J Sung, S Nag… - Proceedings of the …, 2013 - National Acad Sciences
Cardiovascular disorders are the leading cause of morbidity and mortality in the developed
world, and hypertrophic cardiomyopathy (HCM) is among the most frequently occurring …

Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor

JR Moore, L Leinwand, DM Warshaw - Circulation research, 2012 - Am Heart Assoc
Hypertrophic (HCM) and dilated (DCM) cardiomyopathies are inherited diseases with a high
incidence of death due to electric abnormalities or outflow tract obstruction. In many of the …

Hypertrophic cardiomyopathy: mutations to mechanisms to therapies

M Kawana, JA Spudich, KM Ruppel - Frontiers in Physiology, 2022 - frontiersin.org
Hypertrophic cardiomyopathy (HCM) affects more than 1 in 500 people in the general
population with an extensive burden of morbidity in the form of arrhythmia, heart failure, and …

Thin filament mutations: developing an integrative approach to a complex disorder

JC Tardiff - Circulation research, 2011 - Am Heart Assoc
Sixteen years ago, mutations in cardiac troponin (Tn) T and α-tropomyosin were linked to
familial hypertrophic cardiomyopathy, thus transforming the disorder from a disease of the β …

Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes

JC Tardiff - Heart failure reviews, 2005 - Springer
Hypertrophic Cardiomyopathy (HCM) is a relatively common primary cardiac disorder
defined as the presence of a hypertrophied left ventricle in the absence of any other …

Left ventricular strain is abnormal in preclinical and overt hypertrophic cardiomyopathy: cardiac MR feature tracking

DM Vigneault, E Yang, PJ Jensen, MW Tee, H Farhad… - Radiology, 2019 - pubs.rsna.org
Purpose To evaluate myocardial strain and circumferential transmural strain difference
(cTSD; the difference between epicardial and endocardial circumferential strain) in a …

Age-related slowing of myosin actin cross-bridge kinetics is sex specific and predicts decrements in whole skeletal muscle performance in humans

MS Miller, NG Bedrin, DM Callahan… - Journal of applied …, 2013 - journals.physiology.org
We hypothesize that age-related skeletal muscle dysfunction and physical disability may be
partially explained by alterations in the function of the myosin molecule. To test this …